Speaking of Science

» quotes, innovation and genomics

Most Recent

image: Speaking of Science

Speaking of Science

By | February 1, 2016

February 2016's selection of notable quotes

1 Comment

image: Speaking of Science

Speaking of Science

By | January 1, 2016

January 2016's selection of notable quotes

0 Comments

image: Speaking of Science

Speaking of Science

By | September 1, 2015

September 2015's selection of notable quotes

1 Comment

image: Speaking of Science

Speaking of Science

By | August 1, 2015

August 2015's selection of notable quotes

5 Comments

image: Speaking of Science

Speaking of Science

By | July 1, 2015

July 2015's selection of notable quotes

5 Comments

image: Speaking of Science

Speaking of Science

By | June 1, 2015

June 2015's selection of notable quotes

2 Comments

image: Speaking of Science

Speaking of Science

By | May 1, 2015

May 2015's selection of notable quotes

1 Comment

image: Speaking of Science

Speaking of Science

By | March 1, 2015

March 2015's selection of notable quotes

3 Comments

image: Speaking of Science

Speaking of Science

By | February 1, 2015

February 2015's selection of notable quotes

0 Comments

image: Speaking of Science

Speaking of Science

By | January 1, 2015

January 2015's selection of notable quotes

2 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham